Reference
Qin B-D, et al. The effectiveness of afatinib and osimertinib in a chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): A case report and literature review. OncoTargets and Therapy 11: 4739-4745, 10 Aug 2018. Available from: URL: http://doi.org/10.2147/OTT.S167346 - China
Rights and permissions
About this article
Cite this article
Afatinib/cisplatin/pemetrexed. Reactions Weekly 1737, 17 (2019). https://doi.org/10.1007/s40278-019-57112-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-57112-9